NCT07498075

Brief Summary

This study evaluates whether different types of digital health communication can increase parents' intention to vaccinate their daughters against human papillomavirus (HPV) in Nigeria. HPV vaccination is recommended for girls aged 9-14 years and helps prevent cervical cancer, yet vaccination rates remain low. Parents of eligible, unvaccinated girls will be randomly assigned to receive one of several types of digital content delivered online. These include: (1) a short chatbot conversation based on motivational interviewing principles, (2) an interactive game designed to help parents recognize and resist common forms of vaccine misinformation, (3) a set of short edutainment videos about HPV vaccination, (4) standard informational infographics about HPV vaccination from a national public health agency, or (5) unrelated health content about menstruation. The main outcome is parents' self-reported intention to vaccinate their daughter against HPV, measured immediately and one week after exposure to the assigned content. Additional outcomes include HPV-related knowledge, perceptions of vaccine safety, willingness to recommend the vaccine to others, and self-reported vaccine uptake at 1-week and 6 month follow-up. The results will help inform scalable communication strategies to improve HPV vaccination uptake in low- and middle-income settings.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,340

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started May 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress13%
May 2026Dec 2026

First Submitted

Initial submission to the registry

March 23, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 27, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

May 18, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 20, 2026

Status Verified

May 1, 2026

Enrollment Period

8 months

First QC Date

March 23, 2026

Last Update Submit

May 18, 2026

Conditions

Keywords

HPVHPV VaccineChatbotsMisinformationPre-Bunking

Outcome Measures

Primary Outcomes (2)

  • HPV Vaccination Intention (1-Week Post-Intervention)

    Parent's self-reported intention to vaccinate their selected daughter (aged 9-14 years) against HPV, measured on a 10-point numeric scale, where higher values indicate greater intention to vaccinate. If a participant has more than one eligible daughter, one daughter is randomly selected for all outcome questions.

    1 week after exposure to the assigned intervention content

  • HPV Vaccination Intention (Immediately Post-Intervention)

    Parent's self-reported intention to vaccinate their selected daughter against HPV, measured on a 10-point numeric scale.

    Immediately Post-Intervention

Secondary Outcomes (12)

  • HPV Vaccination Intention (6 months post-intervention)

    6 months post-intervention

  • Self-Reported HPV Vaccine Uptake

    6 months post-intervention

  • Perceived Safety of the HPV Vaccine

    1 week post-intervention, 6 months post-intervention

  • Likelihood of Recommending the HPV Vaccine to Other Parents

    1 week post-intervention, 6 months post-intervention

  • Self-Reported Knowledge of the HPV Vaccine

    1 week post-intervention, 6 months post-intervention

  • +7 more secondary outcomes

Other Outcomes (1)

  • Engagement With Assigned Intervention Content

    During intervention exposure

Study Arms (5)

Chatbot counseling arm

EXPERIMENTAL

A brief motivational-interviewing-style chatbot dialogue adapted from WHO vaccination counseling guidance

Behavioral: Chatbot counseling

Misinformation-resistance pre-bunking inoculation arm

EXPERIMENTAL

A short interactive game (approximately 3-5 minutes) designed to build resistance to HPV vaccine misinformation

Behavioral: Misinformation-resistance pre-bunking inoculation

Short edutainment arm

EXPERIMENTAL

5-6 brief edutainment videos (total viewing time approximately 10-15 minutes) providing HPV vaccine information tailored to the Nigerian context

Behavioral: Short edutainment

Standard infographic control arm

ACTIVE COMPARATOR

Existing infographics on HPV vaccination from Nigeria's National Primary Health Care Development Agency (NPHCDA)

Behavioral: Standard infographic control

Unrelated content control arm

NO INTERVENTION

Series of infographics on menstruation from Nigeria's Menstrual Health Advocacy Consortium

Interventions

A brief motivational-interviewing-style chatbot dialogue adapted from WHO vaccination counseling guidance

Chatbot counseling arm

A short interactive game (approximately 3-5 minutes) designed to build resistance to HPV vaccine misinformation

Misinformation-resistance pre-bunking inoculation arm

5-6 brief edutainment videos (total viewing time approximately 10-15 minutes) providing HPV vaccine information tailored to the Nigerian context

Short edutainment arm

Existing infographics on HPV vaccination from Nigeria's National Primary Health Care Development Agency (NPHCDA)

Standard infographic control arm

Eligibility Criteria

Age27 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Parent or primary caregiver of at least one girl aged 9-14 years
  • Parent states "no" or "unsure" to question asking if eligible daughter has received any doses of the HPV vaccine
  • Provides informed consent to participate

You may not qualify if:

  • Parent or caregiver of a girl who has already received one or more doses of the HPV vaccine
  • Does not meet age eligibility criteria for an eligible daughter
  • Fails Attention Checks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Communication

Condition Hierarchy (Ancestors)

Behavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 23, 2026

First Posted

March 27, 2026

Study Start

May 18, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 20, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

De-identified individual participant data underlying the primary and secondary outcome analyses will be shared. This includes randomized treatment assignment, baseline covariates, outcome measures related to HPV vaccination intention, knowledge, attitudes, and self-reported vaccine uptake, as well as basic demographic variables. Data will be de-identified prior to sharing and will not include direct identifiers or information that could reasonably be used to re-identify participants.